AU469472B2 - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number: AU469472B2
Authority: AU; Australia
Prior art keywords: tablet formulation; formulation; tablet
Prior art date: 1973-05-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

AU69252/74A

Other languages

English (en)

Other versions

AU6925274A (en

Inventor

HARDEN and ALLAN JOHN TORODE DAVID

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wellcome Foundation Ltd

Original Assignee

Wellcome Foundation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-05-23

Filing date

1974-05-22

Publication date

1976-02-12

1974-05-22 Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd

1975-11-27 Publication of AU6925274A publication Critical patent/AU6925274A/en

1976-02-12 Application granted granted Critical

1976-02-12 Publication of AU469472B2 publication Critical patent/AU469472B2/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU69252/74A 1973-05-23 1974-05-22 Tablet formulation Expired AU469472B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB24628/73		1973-05-23
GB2462873A GB1460302A (en)	1973-05-23	1973-05-23	Tablet formulation

Publications (2)

Publication Number	Publication Date
AU6925274A AU6925274A (en)	1975-11-27
AU469472B2 true AU469472B2 (en)	1976-02-12

Family

ID=10214700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU69252/74A Expired AU469472B2 (en)	1973-05-23	1974-05-22	Tablet formulation

Country Status (21)

Country	Link
JP (1)	JPS577128B2 (it)
AT (1)	AT351167B (it)
AU (1)	AU469472B2 (it)
BE (1)	BE815409A (it)
CA (1)	CA977279A (it)
CY (1)	CY941A (it)
DE (1)	DE2424950A1 (it)
DK (1)	DK144261C (it)
FI (1)	FI156674A (it)
FR (1)	FR2230341B1 (it)
GB (1)	GB1460302A (it)
HK (1)	HK1378A (it)
HU (1)	HU170656B (it)
IE (1)	IE39283B1 (it)
IL (1)	IL44877A (it)
IT (1)	IT8048966A0 (it)
KE (1)	KE2808A (it)
MY (1)	MY7800181A (it)
NL (1)	NL190436C (it)
SE (1)	SE402525C (it)
ZA (1)	ZA743318B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1533243A (en) *	1975-02-13	1978-11-22	Wellcome Found	Tablet formulation
US4143129A (en)	1975-10-11	1979-03-06	Lilly Industries Limited	Cephalexin tablets
US4115563A (en) *	1977-03-14	1978-09-19	Sterling Drug Inc.	Pharmaceutical steroid formulation
GB1601833A (en) *	1978-02-06	1981-11-04	Wellcome Found	Antacid formulation
DE3839825A1 (de) *	1988-11-25	1990-06-13	Henning Berlin Gmbh	Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
WO1996002234A1 (es) *	1994-07-18	1996-02-01	Luis Cipriano Carvajal Martin	Granulos compactos altamente autodisgregantes para uso en formas galenicas conteniendo principios activos insolubles o poco solubles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB975850A (en) *	1955-08-10	1964-11-18	Wellcome Found	Xanthine oxidase inhibitors
US3624205A (en) *	1967-04-25	1971-11-30	Burroughs Wellcome Co	Treatment of hyperuricemia in humans

1973
- 1973-05-23 GB GB2462873A patent/GB1460302A/en not_active Expired
1974
- 1974-05-22 ZA ZA00743318A patent/ZA743318B/xx unknown
- 1974-05-22 DE DE19742424950 patent/DE2424950A1/de active Pending
- 1974-05-22 IE IE1097/74A patent/IE39283B1/xx unknown
- 1974-05-22 CA CA200,536A patent/CA977279A/en not_active Expired
- 1974-05-22 SE SE7406864A patent/SE402525C/sv not_active IP Right Cessation
- 1974-05-22 IL IL44877A patent/IL44877A/en unknown
- 1974-05-22 NL NLAANVRAGE7406873,A patent/NL190436C/xx not_active IP Right Cessation
- 1974-05-22 HU HUWE507A patent/HU170656B/hu unknown
- 1974-05-22 BE BE144636A patent/BE815409A/xx not_active IP Right Cessation
- 1974-05-22 JP JP5776774A patent/JPS577128B2/ja not_active Expired
- 1974-05-22 FI FI1566/74A patent/FI156674A/fi unknown
- 1974-05-22 AT AT426774A patent/AT351167B/de not_active IP Right Cessation
- 1974-05-22 DK DK280174AA patent/DK144261C/da not_active IP Right Cessation
- 1974-05-22 FR FR7417820A patent/FR2230341B1/fr not_active Expired
- 1974-05-22 AU AU69252/74A patent/AU469472B2/en not_active Expired
- 1974-05-23 CY CY941A patent/CY941A/xx unknown
- 1974-12-02 KE KE2808A patent/KE2808A/xx unknown
1978
- 1978-01-05 HK HK13/78A patent/HK1378A/xx unknown
- 1978-12-31 MY MY1978181A patent/MY7800181A/xx unknown
1980
- 1980-06-13 IT IT8048966A patent/IT8048966A0/it unknown

Also Published As

Publication number	Publication date
IL44877A (en)	1976-11-30
FR2230341B1 (it)	1977-04-15
JPS577128B2 (it)	1982-02-09
FR2230341A1 (it)	1974-12-20
JPS5040721A (it)	1975-04-14
HK1378A (en)	1978-01-13
KE2808A (en)	1978-02-17
HU170656B (it)	1977-07-28
BE815409A (fr)	1974-11-22
IL44877A0 (en)	1974-07-31
ATA426774A (de)	1978-12-15
ZA743318B (en)	1975-05-28
IT8048966A0 (it)	1980-06-13
GB1460302A (en)	1977-01-06
DK144261C (da)	1991-02-04
CA977279A (en)	1975-11-04
IE39283L (en)	1974-11-23
AT351167B (de)	1979-07-10
NL190436B (nl)	1993-10-01
IE39283B1 (en)	1978-09-13
NL190436C (nl)	1994-03-01
NL7406873A (it)	1974-11-26
AU6925274A (en)	1975-11-27
CY941A (en)	1978-06-23
DE2424950A1 (de)	1974-12-19
SE402525B (sv)	1978-07-10
SE402525C (sv)	1982-11-22
MY7800181A (en)	1978-12-31
FI156674A (it)	1974-11-24
DK144261B (it)	1982-02-01

Publication	Publication Date	Title
CA1030871A (en)	1978-05-09	Pharmaceutical compositions
CA983907A (en)	1976-02-17	Stand
AU474137B2 (en)	1976-07-15	Auto-refractometer
CA1026673A (en)	1978-02-21	Pharmaceutical compositions
AU468964B2 (en)	1976-01-29	Melik
CA1014924A (en)	1977-08-02	Anti-retrieval devices
CA977503A (en)	1975-11-11	Rinse-wax formulation
AU498989B2 (en)	1979-03-29	Pharmaceutical compositions
CA989701A (en)	1976-05-25	Horizontal type hydrohoist
AU475742B2 (en)	1976-09-02	Devices
AU476397B2 (en)	1976-09-16	A-cycloalkylbenzyl lactamimides
AU476505B2 (en)	1976-09-23	Alkylbenxyl lactamimides
ZA7461B (en)	1975-08-27	Pharmaceutical formulation
CA1001361A (en)	1976-12-14	Bleaching formulation
AU472907B2 (en)	1976-06-10	Firecheck
AU469472B2 (en)	1976-02-12	Tablet formulation
AU468465B2 (en)	1976-01-15	Tablet formulation
AU476386B2 (en)	1976-09-16	Dibenzocycloheptenyl lactamimides
AU471241B2 (en)	1976-04-15	Benzothiazolylureas
AU480426B2 (en)	1975-11-06	Pharmaceutical tablets
AU6853574A (en)	1975-11-06	Pharmaceutical tablets
CA996115A (fr)	1976-08-31	Piperazino-pyrimidines utilisables comme medicaments
AU492729B2 (en)	1975-10-02	Pharmaceutical compositions
AU478769B2 (en)	1975-09-18	Pharmaceutical compositions
AU485568B2 (en)	1976-01-22	Pharmaceutical compositions